As used in this part, the following definitions apply:
- (1) "Canopy" means the total amount of square footage dedicated to live plant production at a registered premises consisting of the area of the floor, platform, or means of support or suspension of the plant.
- (2) "Chemical manufacturing" means the production of marijuana concentrate.
- (3) "Correctional facility or program" means a facility or program that is described in 53-1-202 and to which an individual may be ordered by any court of competent jurisdiction.
(4) "Debilitating medical condition" means:
- (a) cancer, glaucoma, positive status for human immunodeficiency virus, or acquired immune deficiency syndrome when the condition or disease results in symptoms that seriously and adversely affect the patient's health status;
- (b) cachexia or wasting syndrome;
- (c) severe chronic pain that is persistent pain of severe intensity that significantly interferes with daily activities as documented by the patient's treating physician;
- (d) intractable nausea or vomiting;
- (e) epilepsy or an intractable seizure disorder;
- (f) multiple sclerosis;
- (g) Crohn's disease;
- (h) painful peripheral neuropathy;
- (i) a central nervous system disorder resulting in chronic, painful spasticity or muscle spasms;
- (j) admittance into hospice care in accordance with rules adopted by the department; or
- (k) posttraumatic stress disorder.
- (5) "Department" means the department of public health and human services provided for in 2-15-2201.
- (6) "Dispensary" means a registered premises from which a provider or marijuana-infused products provider is approved by the department to dispense marijuana or marijuana-infused products to a registered cardholder.
(7)
- (a) "Employee" means an individual employed to do something for the benefit of an employer or a third person.
- (b) The term includes a manager, agent, or director of a partnership, association, company, corporation, limited liability company, or organization.
- (8) "Local government" means a county, a consolidated government, or an incorporated city or town.
- (9) "Marijuana" has the meaning provided in 50-32-101.
- (10) "Marijuana concentrate" means any type of marijuana product consisting wholly or in part of the resin extracted from any part of the marijuana plant.
- (11) "Marijuana derivative" means any mixture or preparation of the dried leaves, flowers, resin, and byproducts of the marijuana plant, including but not limited to marijuana concentrates and marijuana-infused products.
(12)
- (a) "Marijuana-infused product" means a product that contains marijuana and is intended for use by a registered cardholder by a means other than smoking.
- (b) The term includes but is not limited to edible products, ointments, and tinctures.
(13)
- (a) "Marijuana-infused products provider" means a person licensed by the department to manufacture and provide marijuana-infused products for a registered cardholder.
- (b) The term does not include the cardholder's treating or referral physician.
- (14) "Mature marijuana plant" means a harvestable female marijuana plant that is flowering.
- (15) "Paraphernalia" has the meaning provided in 45-10-101.
- (16) "Person" means an individual, partnership, association, company, corporation, limited liability company, or organization.
(17)
- (a) "Provider" means a person licensed by the department to assist a registered cardholder as allowed under this part.
- (b) The term does not include a cardholder's treating physician or referral physician.
(18) "Referral physician" means an individual who:
- (a) is licensed under Title 37, chapter 3;
- (b) has an established office in Montana; and
- (c) is the physician to whom a patient's treating physician has referred the patient for physical examination and medical assessment.
- (19) "Registered cardholder" or "cardholder" means a Montana resident with a debilitating medical condition who has received and maintains a valid registry identification card.
(20) "Registered premises" means the location at which a provider or marijuana-infused products provider:
- (a) has indicated that marijuana will be cultivated, chemical manufacturing will occur, or marijuana-infused products will be manufactured for a registered cardholder; or
- (b) has established a dispensary for sale of marijuana or marijuana-infused products to a registered cardholder.
- (21) "Registry identification card" means a document issued by the department pursuant to 50-46-303 that identifies an individual as a registered cardholder.
(22)
- (a) "Resident" means an individual who meets the requirements of 1-1-215.
(b) An individual is not considered a resident for the purposes of this part if the individual:
- (i) claims residence in another state or country for any purpose; or
- (ii) is an absentee property owner paying property tax on property in Montana.
- (23) "Second degree of kinship by blood or marriage" means a mother, father, brother, sister, son, daughter, spouse, grandparent, grandchild, mother-in-law, father-in-law, brother-in-law, sister-in-law, son-in-law, daughter-in-law, grandparent-in-law, grandchild-in-law, stepfather, stepmother, stepbrother, stepsister, stepson, stepdaughter, stepgrandparent, or stepgrandchild.
- (24) "Seedling" means a marijuana plant that has no flowers and is less than 12 inches in height and 12 inches in diameter.
(25) "Standard of care" means, at a minimum, the following activities when undertaken by a patient's treating physician or referral physician if the treating physician or referral physician is providing written certification for a patient with a debilitating medical condition:
- (a) obtaining the patient's medical history;
- (b) performing a relevant and necessary physical examination;
- (c) reviewing prior treatment and treatment response for the debilitating medical condition;
- (d) obtaining and reviewing any relevant and necessary diagnostic test results related to the debilitating medical condition;
- (e) discussing with the patient and ensuring that the patient understands the advantages, disadvantages, alternatives, potential adverse effects, and expected response to the recommended treatment;
- (f) monitoring the response to treatment and possible adverse effects; and
- (g) creating and maintaining patient records that remain with the physician.
(26) "Testing laboratory" means a qualified person, licensed by the department, who meets the requirements of 50-46-311 and:
- (a) provides testing of small samples of marijuana and marijuana-infused products; and
- (b) provides information regarding the chemical composition, the potency of a sample, and the presence of molds or pesticides in a sample.
(27) "Treating physician" means an individual who:
- (a) is licensed under Title 37, chapter 3;
- (b) has an established office in Montana; and
- (c) has a bona fide professional relationship with the individual applying to be a registered cardholder.
(28)
- (a) "Usable marijuana" means the dried leaves and flowers of the marijuana plant and any marijuana derivatives that are appropriate for the use of marijuana by an individual with a debilitating medical condition.
- (b) The term does not include the seeds, stalks, and roots of the plant.
- (29) "Written certification" means a statement signed by a treating physician or referral physician that meets the requirements of 50-46-310 and is provided in a manner that meets the standard of care.
History: En. Sec. 2, Ch. 419, L. 2011; amd. Sec. 4, I.M. No. 182, approved Nov. 8, 2016; amd. Sec. 2, Ch. 408, L. 2017.